BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

Amaran Biotech Achieves FDA Acknowledgement for Type II DMF of AB801 Vaccine Adjuvant

Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vacc...

December 03, 2025 | News

Antengene Secures NMPA Approval for IND of CLINCH Two Combination Study in Gastric Cancer

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, develop...

December 03, 2025 | News

NADMED Launches Global Award to Unlock the Secrets of Cellular Redox Metabolism

As scientists seek to understand the molecular basis of energy production, aging, and disease, one area remains especially elusive: cellular redox metaboli...

December 03, 2025 | News

Neurophet and the Florey Institute Begin Joint Research To Advance High Precision Dementia Diagnosis

Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and management Joint research to enhance dementia d...

November 26, 2025 | News

Pin Therapeutics Begins First Human Study of CK1 Alpha Degrader PIN 5018 for Rare Cancer

Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced on November 20 that it has...

November 25, 2025 | News

Aspen Neuroscience Secures $115 Million Series C to Advance Personalised Cell Therapy for Parkinson’s Disease

Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, announced the closing of a $115 millio...

November 21, 2025 | News

ReviR Therapeutics Wins CIRM Grant to Advance First in Class Dual Target Therapy for Huntington’s Disease

ReviR Therapeutics, a biotech company focused on developing innovative treatments for neurogenetic diseases, announced that it has been awarded a $4....

November 21, 2025 | News

Tsingke Biotech Showcases Breakthrough Speed in Protein and Antibody Development at PEGS Europe 2025

At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest ac...

November 20, 2025 | News

YolTech Therapeutics Receives FDA Clearance to Begin Pivotal Trial for In Vivo Gene Editing Therapy in PH1

YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food ...

November 20, 2025 | News

Bio Techne Licenses AI Designed NovoBody Duo Molecules Under Exclusive Agreement With Monod Bio

Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...

November 19, 2025 | News

Volta Labs Expands Callisto Automation Through Strategic Partnership with New England Biolabs

Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned provider of life science reagents,&nb...

November 17, 2025 | News

LISCure Biosciences Secures Fourth Global Evaluation Partner for Its Next Generation BBB Shuttle Platform ExoPN 101

LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Materi...

November 14, 2025 | News

Strategic Transaction Positions Crown Bioscience for Global Expansion in Translational Oncology

Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology JSR Life Sciences, a global leader in life sci...

November 14, 2025 | News

Teijin and BioVaram Form Strategic Alliance To Advance Regenerative Medicine and Implantable Medical Technologies Across Japan and India

Teijin Limited and BioVaram, the brand name of the UR Advanced Therapeutics Pvt Ltd. (URAT), announced today ...

November 13, 2025 | News

Stay Connected